Related references
Note: Only part of the references are listed.Bacteriophages as Therapeutic and Prophylactic Means: Summary of the Soviet and Post Soviet Experiences
Nina Chanishvili
CURRENT DRUG DELIVERY (2016)
Encapsulation of Bacteriophage in Liposome Accentuates Its Entry in to Macrophage and Shields It from Neutralizing Antibodies
Saloni Singla et al.
PLOS ONE (2016)
Oral Application of T4 Phage Induces Weak Antibody Production in the Gut and in the Blood
Joanna Majewska et al.
VIRUSES-BASEL (2015)
Strain Specific Phage Treatment for Staphylococcus aureus Infection Is Influenced by Host Immunity and Site of Infection
Nathan B. Pincus et al.
PLOS ONE (2015)
Phage Neutralization by Sera of Patients Receiving Phage Therapy
Marzanna Lusiak-Szelachowska et al.
VIRAL IMMUNOLOGY (2014)
Effect of rituximab on human in vivo antibody immune responses
Mark D. Pescovitz et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Experimental phage therapy against Staphylococcus aureus in mice
Rosanna Capparelli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Bacteriophage translocation
A Górski et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2006)
Oral tolerance: Therapeutic implications for autoimmune diseases
Ana M. C. Faria et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2006)
Human volunteers receiving Escherichia coli phage T4 orally:: a safety test of phage therapy
A Bruttin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Bacteriophage therapy
A Sulakvelidze et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Share Paper
